Related references
Note: Only part of the references are listed.An open label trial of anakinra to prevent respiratory failure in COVID-19
Evdoxia Kyriazopoulou et al.
ELIFE (2021)
Soluble Urokinase Plasminogen Activator Receptor as a Decision Marker for Early Discharge of Patients with COVID-19 Symptoms in the Emergency Department
Marius Ahm Stauning et al.
JOURNAL OF EMERGENCY MEDICINE (2021)
Soluble Urokinase Receptor and Acute Kidney Injury
Salim S. Hayek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
High suPAR and Low Blood Eosinophil Count are Risk Factors for Hospital Readmission and Mortality in Patients with COPD
Kjell E. J. Hakansson et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2020)
Prognostic Role of Soluble Urokinase Plasminogen Activator Receptor at the Emergency Department: A Position Paper by the Hellenic Sepsis Study Group
Dimitrios Velissaris et al.
INFECTIOUS DISEASES AND THERAPY (2020)
Soluble Urokinase Receptor (SuPAR) in COVID-19-Related AKI
Tariq U. Azam et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia
Nikoletta Rovina et al.
CRITICAL CARE (2020)
Do we know the diagnostic properties of the tests used in COVID-19? A rapid review of recently published literature
Vivienne C. Bachelet
MEDWAVE (2020)
Soluble Urokinase Receptor and Acute Kidney Injury
Ulf Schoenermarck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Early Discharge from the Emergency Department Based on Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels: A TRIAGE III Substudy
Martin Schultz et al.
DISEASE MARKERS (2019)
Levels of Soluble Urokinase Plasminogen Activator Receptor in Pediatric Lower Respiratory Tract Infections
Hale Citlenbik et al.
PEDIATRIC ALLERGY IMMUNOLOGY AND PULMONOLOGY (2019)
Combining National Early Warning Score With Soluble Urokinase Plasminogen Activator Receptor (suPAR) Improves Risk Prediction in Acute Medical Patients: A Registry-Based Cohort Study*
Line J. H. Rasmussen et al.
CRITICAL CARE MEDICINE (2018)
Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD
Nina S. Godtfredsen et al.
RESPIRATORY RESEARCH (2018)
Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study
Line Jee Hartmann Rasmussen et al.
EMERGENCY MEDICINE JOURNAL (2016)
Plasma Levels of Soluble Urokinase-Type Plasminogen Activator Receptor Associate with the Clinical Severity of Acute Puumala Hantavirus Infection
Tuula K. Outinen et al.
PLOS ONE (2013)
Soluble Urokinase Plasminogen Activator Receptor is Associated With Progressive Liver Fibrosis in Hepatitis C Infection
Marie-Luise Berres et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2012)
Assessment of simple risk markers for early mortality among HIV-infected patients in Guinea-Bissau: a cohort study
Ines Oliveira et al.
BMJ OPEN (2012)
The diagnostic and prognostic significance of soluble urokinase plasminogen activator receptor in Crimean-Congo hemorrhagic fever
Gurdal Yilmaz et al.
JOURNAL OF CLINICAL VIROLOGY (2011)
Share Paper
